BeStock  
Stocks › Biotechnology › TBPH

Theravance Biopharma(Delisted) TBPH

US equityMarket cap rank #3238Biotechnology
$0.00 +$0.00 (0.00%)
Market closed · Oct 24, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$884.18M
P/E (TTM)16.4
Dividend yield–

TBPH at a glance

TBPH last changed hands at $0.00 (flat). At $884.18M, Theravance Biopharma(Delisted) is ranked #3238 by size among the 3753 stocks on BeStock.

In the quarter ended Jun 2026 the company brought in $20.73M of revenue, down 20.9% from a year earlier, and a net loss of $5.90M.

Buyers are paying 16.4 times trailing earnings, 698% above its five-year average of 2.1. The median for its industry group is 17.1.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Volume0.00
Market cap$884.18M
Float market cap$440.57M
Shares outstanding25.87M
EPS (TTM)$2.06
P/E (TTM)16.38
P/B3.05
Book value / share$5.58
Earnings yield6.11%
Net profit (TTM)$106.95M
Net assets$289.71M

Quote as of Oct 24, 2026 12:40 am ET. Prices can lag the live tape. This is background information, not a recommendation.

Six-factor research snapshot

Overall percentile: 86.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation39.8
Growth44.5
Profitability90.7
Momentum—
Financial health97.0
Analyst view—

TBPH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on TBPH.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on TBPH

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

TBPH stock: common questions

How is Theravance Biopharma(Delisted) stock doing today?

$0.00 is the latest print for TBPH, a move of +0.00% against yesterday's close of $0.00. Today's low and high so far: $0.00 and $0.00.

How large is Theravance Biopharma(Delisted) by market value?

Equity value comes to $884.18M at the current price. By that measure it is number 3238 of the 3753 names in our coverage.

What multiple of earnings does TBPH sell for?

Buyers pay 16.4 times the last twelve months of profit (EPS $2.06). Averaged over five years the multiple has been 2.1, and today's level ranks in the 85th percentile of its own history.

Does Theravance Biopharma(Delisted) pay a dividend?

Our data shows no dividend paid by Theravance Biopharma(Delisted) over the trailing twelve months.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on TBPH.

Sign in to join the discussion.

Scroll to Top